Atlas Trials

The Efficacy and Safety of Corticosteroids in Combination With Ruxolitinib in the Management of Checkpoint Inhibitor Pneumonia

Clinical trial NCT05899725 · COMPLETED

Trial details

NCT number
NCT05899725
Sponsor
Peking Union Medical College Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Severe Checkpoint Inhibitor Pneumonitis
Start date
2023-04-14
Primary completion
2026-03-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.